FdaApplication
ANDA 212033
Identifiers
- fda_app_no: ANDA212033
Properties
| Property | Value |
|---|---|
| applicant_name | YICHANG HUMANWELL PHARMACEUTICAL CO LTD |
| application_type | ANDA |
| approval_date | 2019-08-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROXEN SODIUM | NAPROXEN SODIUM | 220MG | TABLET;ORAL |
1 product